191 related articles for article (PubMed ID: 27509936)
1. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
[TBL] [Abstract][Full Text] [Related]
2. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
Osamura RY
Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
[TBL] [Abstract][Full Text] [Related]
3. Benefits of Cervical Cancer Screening by Liquid-Based Cytology as Part of Routine Antenatal Assessment.
Parkpinyo N; Inthasorn P; Laiwejpithaya S; Punnarat T
Asian Pac J Cancer Prev; 2016; 17(9):4457-4461. PubMed ID: 27797261
[TBL] [Abstract][Full Text] [Related]
4. Cervical cytological screening results of 8,495 cases in Turkey--common inflammation but infrequent epithelial cell abnormalities?
Daloglu FT; Karakaya YA; Balta H; Altun E; Duman A
Asian Pac J Cancer Prev; 2014; 15(13):5127-31. PubMed ID: 25040962
[TBL] [Abstract][Full Text] [Related]
5. Metastatic breast cancer diagnosed on cervical cytology.
Yuan L; Oshilaja O; Sierk A; Zhang G; Booth CN; Brainard J; Dyhdalo KS
Cytopathology; 2021 Jan; 32(1):127-131. PubMed ID: 32789952
[No Abstract] [Full Text] [Related]
6. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
[TBL] [Abstract][Full Text] [Related]
7. Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.
Whop LJ; Baade P; Garvey G; Cunningham J; Brotherton JM; Lokuge K; Valery PC; O'Connell DL; Canfell K; Diaz A; Roder D; Gertig DM; Moore SP; Condon JR
PLoS One; 2016; 11(4):e0150473. PubMed ID: 27064273
[TBL] [Abstract][Full Text] [Related]
8. Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.
Li Z; Austin RM; Guo M; Zhao C
Arch Pathol Lab Med; 2012 Dec; 136(12):1533-40. PubMed ID: 22900617
[TBL] [Abstract][Full Text] [Related]
9. Cervical cytology in Zambia.
Grech ES; O'Dowd MJ; Tsirkina GA; Zeigler O
Med J Zambia; 1977; 11(4):112-7. PubMed ID: 919781
[TBL] [Abstract][Full Text] [Related]
10. The Bethesda System for Reporting Cervical Cytology: A Historical Perspective.
Nayar R; Wilbur DC
Acta Cytol; 2017; 61(4-5):359-372. PubMed ID: 28693017
[TBL] [Abstract][Full Text] [Related]
11. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
Miller RA; Mody DR; Tams KC; Thrall MJ
Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer in developing countries: effective screening and preventive strategies with an application in Rwanda.
Mukakalisa I; Bindler R; Allen C; Dotson J
Health Care Women Int; 2014; 35(7-9):1065-80. PubMed ID: 24750113
[TBL] [Abstract][Full Text] [Related]
13. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
[TBL] [Abstract][Full Text] [Related]
14. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
Schneider V
Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
[TBL] [Abstract][Full Text] [Related]
15. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
Printz C
Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
[No Abstract] [Full Text] [Related]
16. Outcomes in cervical screening using various cytology technologies: what's age got to do with it?
Barken SS; Rebolj M; Lynge E; Junge J; Rygaard C
Eur J Cancer Prev; 2013 Jul; 22(4):367-73. PubMed ID: 22976387
[TBL] [Abstract][Full Text] [Related]
17. Current status and future trends in cervical cancer screening.
Castle P; Dowdall M
Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
[No Abstract] [Full Text] [Related]
18. Squamous cell carcinoma of the cervix: a cytology-histology-human papillomavirus correlation in clinical practice.
Miller RA; Waters LL; Mody DR; Tams KC
Arch Pathol Lab Med; 2015 Jun; 139(6):776-81. PubMed ID: 26030246
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
Alves C; Alves L; Lunet N
Eur J Cancer Prev; 2009 Nov; 18(6):482-8. PubMed ID: 19734793
[TBL] [Abstract][Full Text] [Related]
20. Prediction of cervical cancer screening using the theory of reasoned action.
Barling NR; Moore SM
Psychol Rep; 1996 Aug; 79(1):77-8. PubMed ID: 8873790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
